Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026)
Beyond Air (XAIR) reported Liabilities and Shareholders Equity of $35.4 million for Q1 2026, up 17.71% on a YoY basis from $30.1 million in Q1 2025, and down 3.78% sequentially from $36.8 million in Q4 2025.
Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
Beyond Air (XAIR) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $35.4 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 17.71% year-over-year to $35.4 million; the trailing twelve-month figure through Mar 2026 stood at $131.2 million (down 19.84% YoY), and the FY2026 full-year result was $35.4 million, up 17.71% from the prior year.
- Liabilities and Shareholders Equity retreated to $35.4 million in Q1 2026, from $36.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $99.2 million in Q1 2022 to a low of $28.1 million in Q2 2025.
- A 5-year average of $55.9 million and a median of $53.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity jumped 144.78% in 2022 and tumbled 47.22% in 2025, its largest moves.
- Tracing XAIR's Liabilities and Shareholders Equity over 5 years: stood at $74.0 million in 2022, then declined by 29.81% to $51.9 million in 2023, then sank by 34.23% to $34.1 million in 2024, then rose by 7.7% to $36.8 million in 2025, then declined by 3.78% to $35.4 million in 2026.
- Business Quant data shows XAIR's Liabilities and Shareholders Equity at $35.4 million in Q1 2026, $36.8 million in Q4 2025, and $31.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Beyond Air | 2.25 Mn | -10.02 Mn | 94,000.00 | 35.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.39 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Sep 30, 2025 | 30.97 Mn |
| Jun 30, 2025 | 28.11 Mn |
| Mar 31, 2025 | 30.06 Mn |
| Dec 31, 2024 | 34.14 Mn |
| Sep 30, 2024 | 53.01 Mn |
| Jun 30, 2024 | 46.50 Mn |
| Mar 31, 2024 | 56.96 Mn |
| Dec 31, 2023 | 51.91 Mn |
| Sep 30, 2023 | 58.01 Mn |
| Jun 30, 2023 | 73.04 Mn |
| Mar 31, 2023 | 68.75 Mn |
| Dec 31, 2022 | 73.96 Mn |
| Sep 30, 2022 | 82.04 Mn |
| Jun 30, 2022 | 91.90 Mn |
| Mar 31, 2022 | 99.20 Mn |
| Dec 31, 2021 | 99.31 Mn |
| Sep 30, 2021 | 54.06 Mn |
| Jun 30, 2021 | 44.17 Mn |